Clinical trials
Recruiting Non-alcoholic Fatty Liver Disease trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2018 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 89bio, Inc. | 2 |
| Akero Therapeutics, Inc | 1 |
| Eli Lilly and Company | 1 |
| German Diabetes Center | 1 |
| GlaxoSmithKline | 1 |
| Newcastle University | 1 |
| Roche Diagnostics GmbH | 1 |
| Technische Universität Dresden | 1 |
| University Hospital Muenster | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 10 |
| Fatty Liver | 4 |
| Fibrosis | 3 |
| Liver Cirrhosis | 3 |
| Cardiovascular Diseases | 2 |
| Diabetes Mellitus | 2 |
| Digestive System Diseases | 2 |
| Liver Diseases | 2 |
| Metabolic Diseases | 2 |
| Obesity | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.